DoctorFinder | Join/Renew | MyAMA | Site Map | Contact Us
Assessing and Treating Persistent Nonmaligant Pain: Common Persistent Pain Conditions

Reference

  1. Gureje O, Von Korff M, Simon GE, Gater R. Persistent pain and well-being: a World Health Organization Study in Primary Care. JAMA. 1998;280:147-151. Learn more.
  2. Deyo RA, Tsui-Wu YJ. Descriptive epidemiology of low-back pain and its related medical care in the United States. Spine. 1987;12:264-268. Learn more.
  3. Boden SD, Davis DO, Dina TS, Patronas NJ, Wiesel SW. Abnormal magnetic resonance scans of the lumbar spine in asymptomatic subjects. A prospective investigation. J Bone Joint Surg Am. 1990;72:403-408. Learn more.
  4. Borenstein DG. Chronic low back pain. Rheum Dis Clin North Am. 1996;22: 439-456. Learn more.
  5. Cohen R, Chopra P, Upshur C. Primary care work-up of acute and chronic symptoms. Geriatrics. 2001;56:26-27.Learn more.
  6. Health Care Guidelines: Adult Low Back Pain. Institute for Clinical Systems Improvement[practice guidelines]. September, 2002. Available at: www.icsi.org. Accessed March 25, 2003.
  7. Deyo RA, Weinstein JN. Low back pain. N Engl J Med. 2001;344:363-370. Learn more.
  8. Wong DA, Mayer TG, Watters WC, et al. North American Spine Society Phase III Clinical Guidelines for Multidisciplinary Spine Care Specialists. LaGrange, IL: North American Spine Society; 2001.
  9. van Tulder MW, Koes BW, Bouter LM. Conservative treatment of acute and chronic nonspecific low back pain. A systematic review of randomized controlled trials of the most common interventions. Spine. 1997;22: 2128-2156. Learn more.
  10. Manniche C, Hesselsoe G, Bentzen L, Christensen I, Lundberg E. Clinical trial of intensive muscle training for chronic low back pain. Lancet. 1988;2:1473-1476. Learn more.
  11. Frost H, Lamb SE, Klaber Moffett JA, Fairbank JC, Moser JS. A fitness programme for patients with chronic low back pain: 2-year follow-up of a randomised controlled trial. Pain. 1998;75:273-279. Learn more.
  12. Hansson TH, Hansson EK. The effects of common medical interventions on pain, back function, and work resumption in patients with chronic low back pain: A prospective 2-year cohort study in six countries. Spine. 2000;25:3055-3064. Learn more.
  13. Sanders SH, Harden RN, Vicente PJ. Evidence-based clinical practice guidelines for interdisciplinary rehabilitation of chronic nonmalignant pain syndrome patients. Pain Pract. 2005 5:303-15.
  14. Guzman J, Esmail R, Karjalainen K, et. al.  Multidisciplinary bio-psycho-social rehabilitation for chronic low back pain. Cochrane Database Syst Rev. 2002;(1):CD000963.
  15. Manheimer E, White A, Berman B, Forys K, Ernst E. Meta-analysis: acupuncture for low back pain. Ann Intern Med. 2005 Apr 19;142(8):651-63.
  16. Bronfort G, Haas M, Evans RL, Bouter LM. Efficacy of spinal manipulation and mobilization for low back pain and neck pain: a systematic review and best evidence synthesis. Spine J. 2004;4:335-56.
  17. Linton SJ, Andersson T. Can chronic disability be prevented? A randomized trial of a cognitive-behavior intervention and two forms of information for patients with spinal pain. Spine. 2000;25:2825-2831. Learn more.
  18. Abdi S, Datta S, Trescot AM, et. al. Epidural steroids in the management of chronic spinal pain: a systematic review. Pain Physician. 2007;10:185-212.
  19. Koes BW, Scholten RJ, Mens JM, Bouter LM. Efficacy of non-steroidal anti-inflammatory drugs for low back pain: a systematic review of randomised clinical trials. Ann Rheum Dis. 1997;56:214-223. Learn more.
  20. Portenoy RK. Current pharmacotherapy of chronic pain. J Pain Symptom Manage. 2000;19:S16-20. Learn more.
  21. Jamison RN, Raymond SA, Slawsby EA, Nedeljkovic SS, Katz NP. Opioid therapy for chronic noncancer back pain. A randomized prospective study. Spine. 1998;23:2591-2600. Learn more.
  22. van Tulder MW, Touray T, Furlan AD, Solway S, Bouter LM. Muscle relaxants for non-specific low back pain. Cochrane Database Syst Rev. 2003:CD004352. Learn more.   
  23. Watts NB, Harris ST, Genant HK. Treatment of painful osteoporotic vertebral fractures with percutaneous vertebroplasty or kyphoplasty. Osteoporos Int. 2001;12:429-437. Learn more. 
  24. Gold DT. The clinical impact of vertebral fractures: quality of life in women with osteoporosis. Bone. 1996;18:185S-189S. Learn more. 
  25. Cook DJ, Guyatt GH, Adachi JD, et al. Quality of life issues in women with vertebral fractures due to osteoporosis. Arthritis Rheum. 1993;36: 750-756. Learn more. 
  26. Measuring quality of life in women with osteoporosis. Osteoporosis Quality of Life Study Group. Osteoporos Int. 1997;7:478-487. Learn more.
  27. Cook DJ, Guyatt GH, Adachi JD, et al. Development and validation of the mini-osteoporosis quality of life questionnaire (OQLQ) in osteoporotic women with back pain due to vertebral fractures. Osteoporosis Quality of Life Study Group. Osteoporos Int. 1999;10:207-213. Learn more. 
  28. McClung BL. Using osteoporosis management to reduce fractures in elderly women. Nurse Pract. 1999;24;26-27. Learn more.
  29. Zetterberg C, Mannius S, Mellstrom D, Rundgren A, Astrand K. Osteoporosis and back pain in the elderly. A controlled epidemiologic and radiographic study. Spine. 1990;15:783-786. Learn more. 
  30. Lyritis GP, Trovas G. Analgesic effects of calcitonin. Bone. 2002;30:71S-74S. Learn more.
  31. Pun KK, Chan LW. Analgesic effect of intranasal salmon calcitonin in the treatment of osteoporotic vertebral fractures. Clin Ther. 1989;11:205-209. Learn more. 
  32. Silverman SL, Azria M. The analgesic role of calcitonin following osteoporotic fracture. Osteoporos Int. 2002;13:858-867. Learn more. 
  33. Clairmont AC, Kidd RL. Rehabilitation of the patient with osteoporosis. Phys Med Rehabil Clin N Am. 1995;6:649-664.  
  34. McGraw JK, Cardella J, Barr JD, et al. Society of interventional radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol. 2003;14:S311-315. Learn more.
  35. McGraw JK, Cardella J, Barr JD, et al. Society of Interventional Radiology quality improvement guidelines for percutaneous vertebroplasty. J Vasc Interv Radiol. 2003;14:827-831. Learn more.
  36. Tanner SB. Back pain, vertebroplasty, and kyphoplasty: treatment of osteoporotic vertebral compression fractures. Bulletin on the Rheumatic Diseases. 2003;52. Learn more.
  37. Phillips FM, Ho E, Campbell-Hupp M, McNally T, Todd Wetzel F, Gupta P. Early radiographic and clinical results of balloon kyphoplasty for the treatment of osteoporotic vertebral compression fractures. Spine. 2003;28:2260-2265. Learn more.
  38. Manek NJ, Lane NE. Baseline Program. In: Moskowitz RW, Howell DS, Altman RD, Buckwalter JA, Goldberg VM, eds. Osteoarthritis: Diagnosis and Medical/Surgical Management. Philadelphia: WB Saunders Company; 2001:361-370.
  39. Simon LS, Lipman AG, Jacox A, et al. Guideline for the Management of Pain in Osteoarthritis, Rheumatoid Arthritis, and Juvenile Chronic Arthritis. 2nd ed. Glenview, IL: American Pain Society; 2002.
  40. Meenan RF, Gertman PM, Mason JH. Measuring health status in arthritis: the Arthritis Impact Measurement Scales. Arthritis Rheum. 1980;23: 146-152.
  41. Fries JF, Spitz P, Krames RG, Holman HR. Measurement of patient outcome in arthritis. Arthritis Rheum. 1980;23:137-145.
  42. Shiely JC, Bayliss MS, Keller SD. SF-36 Health Survey. Boston: The Health Institute, New England Medical Center; 1996.
  43. Lonner JH. A 57-year-old man with osteoarthritis of the knee. JAMA. 2003;289:1016-1025. Learn more.
  44. Edelson R, Burks RT, Bloebaum RD. Short-term effects of knee washout for osteoarthritis. Am J Sports Med. 1995;23:345-349. Learn more.
  45. The management of persistent pain in older persons. J Am Geriatr Soc. 2002;50:S205-224. Learn more.
  46. Schnitzer TJ. Update of ACR guidelines for osteoparthritis: role of the coxibs. J Pain Symptom Manage. 2002;23:S24-30. Learn more.
  47. Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. Arthritis Rheum. 2000;43:1905-1915. Learn more.
  48. Exercise prescription for older adults with osteoarthritis pain: consensus practice recommendations. A supplement to the AGS Clinical Practice Guidelines on the management of chronic pain in older adults. J Am Geriatr Soc. 2001;49:808-823. Learn more.
  49. McAlindon TE, LaValley MP, Felson DT. Efficacy of glucosamine and chondroitin for treatment of osteoarthritis. JAMA. 2000;284:1241. Learn more.
  50. Reginster JY, Deroisy R, Rovati LC, et al. Long-term effects of glucosamine sulphate on osteoarthritis progression: a randomised, placebocontrolled clinical trial. Lancet. 2001;357:251-256. Learn more.
  51. Morreale P, Manopulo R, Galati M, Boccanera L, Saponati G, Bocchi L. Comparison of the antiinflammatory efficacy of chondroitin sulfate and diclofenac sodium in patients with knee osteoarthritis. J Rheumatol. 1996;23:1385-1391. Learn more.
  52. Distler J, Anguelouch A. Evidence-based practice: review of clinical evidence on the efficacy of glucosamine and chondroitin in the treatment of osteoarthritis. J Am Acad Nurse Pract. 2006;18:487-93.
  53. Raynauld JP, Buckland-Wright C, Ward R, et al. Safety and efficacy of long-term intraarticular steroid injections in osteoarthritis of the knee: a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2003;48:370-377.
  54. Kirwan JR, Rankin E. Intra-articular therapy in osteoarthritis. Baillieres Clin Rheumatol. 1997;11:769-794. Learn more.
  55. Moskowitz RW. Hyaluronic acid supplementation. Curr Rheumatol Rep. 2000;2:466-471. Learn more.
  56. Altman RD, Moskowitz RW. Intraarticular sodium hyaluronate (Hyalgan) in the treatment of patients with osteoarthritis of the knee: a randomized clinical trial. Hyalgan Study Group. J Rheumatol. 1998;25:2203-2212. Learn more.
  57. Hochberg MC. Role of intraarticular sodium hyaluronate (Hyalgan) in medical management of osteoarthritis of the knee. Semin Arthritis Rheum.2000;30:2-10.
  58. Gilliand BC. Fibromyalgia. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL, eds. Harrison’s Principles of Internal Medicine. Vol 2. 14 ed. New York: McGraw-Hill Professional; 1998.
  59. Wolfe F, Ross K, Anderson J, Russell IJ, Hebert L. The prevalence and characteristics of fibromyalgia in the general population. Arthritis Rheum. 1995;38:19-28. Learn more. 
  60. Goldenberg DL. Fibromyalgia syndrome a decade later: what have we learned? Arch Intern Med. 1999;159:777-785. Learn more. 
  61. Wolfe F, Smythe HA, Yunus MB, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia. Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990; 33:160-172. Learn more.
  62. Hudson JI, Goldenberg DL, Pope HG, Jr., Keck PE, Jr., Schlesinger L. Comorbidity of fibromyalgia with medical and psychiatric disorders. Am J Med. 1992;92:363-367. Learn more. 
  63. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire: development and validation. J Rheumatol. 1991;18:728-733. Learn more.
  64. Wigers SH, Stiles TC, Vogel PA. Effects of aerobic exercise versus stress management treatment in fibromyalgia. A 4.5 year prospective study. Scand J Rheumatol. 1996;25:77-86. Learn more.
  65. Peters S, Stanley I, Rose M, Kaney S, Salmon P. A randomized controlled trial of group aerobic exercise in primary care patients with persistent, unexplained physical symptoms. Fam Pract. 2002;19:665-674. Learn more.
  66. Schachter CL, Busch AJ, Peloso PM, Sheppard MS. Effects of short versus long bouts of aerobic exercise in sedentary women with fibromyalgia: a randomized controlled trial. Phys Ther. 2003;83:340-358. Learn more.
  67. Fitzcharles MA, Esdaile JM. Nonphysician practitioner treatments and fibromyalgia syndrome. J Rheumatol. 1997;24:937-940. Learn more.
  68. Carette S, Bell MJ, Reynolds WJ, et al. Comparison of amitriptyline, cyclobenzaprine, and placebo in the treatment of fibromyalgia. A randomized, double-blind clinical trial. Arthritis Rheum. 1994;37:32-40. Learn more.
  69. Arnold LM, Hess EV, Hudson JI, et. Al. A randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia. Am J Med. 2002;112:191-7.
  70. Patkar AA, Masand PS, Krulewicz S, et. al. A randomized, controlled, trial of controlled release paroxetine in fibromyalgia. Am J Med. 2007;120:448-54.
  71. Arnold LM, Lu Y, Crofford LJ, Wohlreich M, et al. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis Rheum. 2004;50:2974-84.
  72. Crofford LJ, Rowbotham MC, Mease PJ, et. al. Pregabalin 1008-105 Study Group. Pregabalin for the treatment of fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial. Arthritis Rheum. 2005;52:1264-73.
  73. Arnold LM, Goldenberg DL, Stanford SB, et. al. Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial. Arthritis Rheum. 2007;56:1336-44.
  74. Holman AJ, Myers RR. A randomized, double-blind, placebo-controlled trial of pramipexole, a dopamine agonist, in patients with fibromyalgia receiving concomitant medications. Arthritis Rheum. 2005;52:2495-505.
  75. Russell IJ, Fletcher EM, Michalek JE, McBroom PC, Hester GG. Treatment of primary fibrositis/fibromyalgia syndrome with ibuprofen and alprazolam. A double-blind, placebo-controlled study. Arthritis Rheum. 1991;34:552-560. Learn more.
  76. Bennett RM, Schein J, Kosinski MR, et. al. Impact of fibromyalgia pain on health-related quality of life before and after treatment with tramadol/acetaminophen. Arthritis Rheum. 2005;53:519-27.
  77. Travell J, Simons DG. Myofascial Pain and Dysfunction: The Trigger Point Manual. Baltimore: Williams & Wilkins; 1983.
  78. Alvarez DJ, Rockwell PG. Trigger points: diagnosis and management. Am Fam Physician. 2002;65:653-660. Learn more.
  79. Garvey TA, Marks MR, Wiesel SW. A prospective, randomized, doubleblind evaluation of trigger-point injection therapy for low-back pain. Spine. 1989;14:962-964. Learn more.
  80. Scher HI, Stewart WF, Liberman J, Lipton RB. Prevalence of recurrent headache in population sample. Headache. 1998;38:497-506.
  81. Silberstein SD, Lipton RB, Goadsby PJ. Headache in Clinical Practice. Oxford, UK: Isis Medical Media; 1998.
  82. Silberstein SD, Lipton RB, Dalessio DJ, eds. Wolfe’s Headache and Other Head Pain. Sixth Edition. London: Oxford University Press; 2001.
  83. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8 Suppl 7:1-96. Learn more.
  84. Spierings EL, Schroevers M, Honkoop PC, Sorbi M. Presentation of chronic daily headache: a clinical study. Headache. 1998;38:191-196.
  85. Manzoni GC, MIcieli G. Daily chronic headache. Classification and clinical features: observation on 250 patients. Cephalalgia. 1987;7:169-170.
  86. Kaniecki R. Headache assessment and management. JAMA. 2003;289: 1430-1433. Learn more.
  87. Diamond S, Dalessio DJ, eds. The Practicing Physician’s Approach to Headache. Baltimore, MD: Lippincott, Williams & Wilkins; 1992.
  88. Wiedemann E, Unger J, Blair S, Firesen C, Hart C, Cady R. An open-label study to assess changes in efficacy and satisfaction with migraine care when patients have access to multiple sumatriptan succinate formulations. Clin Ther. 2003;25:235-246. Learn more.
  89. Raskin NH. Headache. 2nd ed. New York: Churchill Livingstone; 1988.
  90. Holroyd KA, O’Donnell FJ, Stensland M, et al. Management of chronic tension-type headache with tricyclic antidepressant medication, stress management therapy, and their combination: a randomized controlled trial. JAMA. 2001;285:2208-2215. Learn more. 
  91. Saper JR, Silberstein SD, Lake AE, 3rd, Winters ME. Double-blind trial of fluoxetine: chronic daily headache and migraine. Headache. 1994;34: 497-502. Learn more.
  92. Foster CA, Bafaloukos J. Paroxetine in the treatment of chronic daily headache. Headache. 1994;34:587-589. Learn more. 
  93. Bendtsen J, Jensen R, Olesen J. A nonselective (amitriptyline), but not a selective (citalopram) serotonin reuptake inhibitor is effective in the prophylactic treatment of chronic tension-type headache. J Neurol Neurosurg Psychiatry. 1996;61.

 

 

Last updated: August 2007
Content provided by: Healthcare Education Products & Standards Group